Fund Overview of UTI Healthcare Fund Direct-growth
-
₹1,146.1 CrAUM
-
₹315.07NAV
-
1.30%Expense Ratio
-
EquityFund Category
Minimum amount you can invest: ₹500
Maximum amount you can invest: ₹1,00,000
We have used a return rate of 15% for our calculations.
Returns of UTI Healthcare Fund Direct-growth
| Tenure | Absolute(%) | Annualised(%) | Category Average(%) |
|---|---|---|---|
| 3 Months | -2.48% | NA | 6.12% |
| 6 Months | -4.06% | NA | 12.92% |
| 1 Year | 3.59% | 3.59% | 6.04% |
| 2 Years | 28.45% | 13.34% | 24.93% |
| 3 Years | 102.56% | 26.53% | 25.71% |
| 5 Years | 116.06% | 16.66% | 19.91% |
| 7 Years | 252.84% | 19.74% | NA |
| 10 Years | 249.68% | 13.34% | 12.78% |
Asset Allocation
equities
98.21%debt instruments
0.01%other assets or cash equivalents
1.79%UTI Healthcare Fund Direct-growth is one Equity mutual fund offered by UTI Mutual Fund. the fund aims Long term capital appreciation. Investment in equity instruments following a value investment strategy across the market capitalization spectrum. It manages assets worth ₹1,146.1 crore as on Thu Jul 31, 2025. The expense ratio stands at 1.3%. Fund Manager Manager EducationAbout UTI Healthcare Fund Direct-growth
The portfolio allocation consists of 98.21% in equities, 0.01% in debt instruments, 1.79% in other assets or cash equivalents.Managed by Kamal Gada, it has delivered a return of 3.59% in the last year, a total return since inception of 15.33%.
To take well-planned investment decisions it helps to also explore best sip suited to individual risk appetite.
Key Metrics of UTI Healthcare Fund Direct-growth
-
Standard Deviation15.67%
-
Sharpe Ratio1.17%
-
Alpha2.04%
-
Beta0.95%
Fund Details
|
|
Top Performing Mutual Funds
| Fund Names | AUM (Cr) | 1M | 3M | 1Yr | 3Yr | 5Yr |
|---|---|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹6,104 | -2.65% | -5.65% | 3.14% | 28.14% | 18.49% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹6,104 | -2.69% | -5.84% | 2.31% | 27.07% | 17.46% |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹872 | -1.70% | 0.27% | 4.54% | 25.80% | 16.15% |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹872 | -1.79% | -0.07% | 3.19% | 24.14% | 14.52% |
More funds from UTI Mutual Fund
| Fund Names | AUM (Cr) | 1M | 3M | 6M | 1Yr | 3Yr |
|---|---|---|---|---|---|---|
|
UTI Healthcare Fund Regular Plan-growth
|
₹1,146 | -2.71% | -2.72% | -4.52% | 2.57% | 25.29% |
|
UTI Healthcare Fund Regular Plan-idcw
|
₹1,146 | -2.71% | -2.72% | -4.52% | 2.57% | 25.29% |
|
UTI Healthcare Fund Direct-idcw
|
₹1,146 | -2.64% | -2.48% | -4.06% | 3.59% | 26.53% |
Mutual Fund Calculator
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
Top Mutual Funds
| Fund Names | AUM (Cr) | NAV | 3Yr | 5Yr | 10Yr |
|---|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹6,104 | ₹37.58 | 27.07% | 17.46% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹6,104 | ₹40.71 | 28.14% | 18.49% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹872 | ₹34.05 | 25.80% | 16.15% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹872 | ₹30.74 | 24.14% | 14.52% | - |
| ICICI Prudential Nifty Healthcare Etf - Growth |
₹146 | ₹148.74 | 25.27% | - | - |
| ICICI Prudential Nifty Pharma Index Fund Direct - Growth |
₹95 | ₹17.54 | 24.22% | - | - |
| ICICI Prudential Nifty Pharma Index Fund - Growth |
₹95 | ₹17.18 | 23.44% | - | - |
| Aditya Birla Sun Life Nifty Healthcare Etf-growth |
₹37 | ₹14.91 | 25.43% | - | - |
Detailed Portfolio
| Stocks | Sector | % of Holding | Value |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | 9.84% | ₹112.82 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 9.76% | ₹109.90 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 9.77% | ₹109.90 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 9.77% | ₹109.90 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 9.61% | ₹105.39 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 9.42% | ₹104.22 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 9.37% | ₹103.18 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 9.07% | ₹95.72 Cr |
| Ajanta Pharma Ltd | Healthcare | 7.16% | ₹78.91 Cr |
| Ajanta Pharma Ltd | Healthcare | 7.04% | ₹77.94 Cr |
| Ajanta Pharma Ltd | Healthcare | 7.30% | ₹77.03 Cr |
| Ajanta Pharma Ltd | Healthcare | 6.48% | ₹72.98 Cr |
| Ajanta Pharma Ltd | Healthcare | 6.25% | ₹70.26 Cr |
| Ajanta Pharma Ltd | Healthcare | 6.25% | ₹70.26 Cr |
| Lupin Ltd | Healthcare | 5.91% | ₹66.54 Cr |
| Lupin Ltd | Healthcare | 5.79% | ₹64.04 Cr |
| Lupin Ltd | Healthcare | 6.02% | ₹63.51 Cr |
| Lupin Ltd | Healthcare | 5.58% | ₹62.75 Cr |
| Lupin Ltd | Healthcare | 5.58% | ₹62.75 Cr |
| Lupin Ltd | Healthcare | 5.65% | ₹62.23 Cr |
| Cipla Ltd | Healthcare | 5.43% | ₹62.18 Cr |
| Ajanta Pharma Ltd | Healthcare | 5.48% | ₹60.16 Cr |
| Cipla Ltd | Healthcare | 5.48% | ₹60.13 Cr |
| Ajanta Pharma Ltd | Healthcare | 4.80% | ₹55.03 Cr |
| Lupin Ltd | Healthcare | 4.70% | ₹51.61 Cr |
| Lupin Ltd | Healthcare | 4.29% | ₹49.19 Cr |
| Procter & Gamble Health Ltd | Healthcare | 4.13% | ₹47.33 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 4.25% | ₹47.01 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 4.12% | ₹46.33 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 4.12% | ₹46.33 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 4.06% | ₹45.74 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 3.99% | ₹45.73 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 4.06% | ₹44.77 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 4.20% | ₹44.35 Cr |
| Procter & Gamble Health Ltd | Healthcare | 3.99% | ₹43.72 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 3.74% | ₹42.17 Cr |
| Cipla Ltd | Healthcare | 3.74% | ₹42.04 Cr |
| Cipla Ltd | Healthcare | 3.74% | ₹42.04 Cr |
| Gland Pharma Ltd | Healthcare | 3.98% | ₹42.02 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 3.75% | ₹41.45 Cr |
| Procter & Gamble Health Ltd | Healthcare | 3.67% | ₹41.32 Cr |
| Procter & Gamble Health Ltd | Healthcare | 3.67% | ₹41.32 Cr |
| Gland Pharma Ltd | Healthcare | 3.65% | ₹41.11 Cr |
| Gland Pharma Ltd | Healthcare | 3.65% | ₹41.11 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 3.74% | ₹41.01 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 3.74% | ₹40.99 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 3.62% | ₹40.71 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 3.62% | ₹40.71 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 3.54% | ₹40.55 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 3.57% | ₹40.12 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 3.57% | ₹40.12 Cr |
| Fortis Healthcare Ltd | Healthcare | 3.48% | ₹39.87 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 3.47% | ₹39.74 Cr |
| Gland Pharma Ltd | Healthcare | 3.62% | ₹39.69 Cr |
| Alkem Laboratories Ltd | Healthcare | 3.52% | ₹39.65 Cr |
| Alkem Laboratories Ltd | Healthcare | 3.52% | ₹39.65 Cr |
| Gland Pharma Ltd | Healthcare | 3.60% | ₹39.61 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 3.58% | ₹39.27 Cr |
| Gland Pharma Ltd | Healthcare | 3.54% | ₹39.22 Cr |
| Alkem Laboratories Ltd | Healthcare | 3.56% | ₹39.06 Cr |
| Divi's Laboratories Ltd | Healthcare | 3.52% | ₹38.92 Cr |
| Gland Pharma Ltd | Healthcare | 3.46% | ₹38.92 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 3.45% | ₹38.88 Cr |
| Fortis Healthcare Ltd | Healthcare | 3.54% | ₹38.79 Cr |
| Alkem Laboratories Ltd | Healthcare | 3.43% | ₹38.66 Cr |
| Alkem Laboratories Ltd | Healthcare | 3.66% | ₹38.61 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 3.48% | ₹38.52 Cr |
| Procter & Gamble Health Ltd | Healthcare | 3.41% | ₹38.35 Cr |
| Alkem Laboratories Ltd | Healthcare | 3.47% | ₹38.35 Cr |
| Cipla Ltd | Healthcare | 3.40% | ₹38.28 Cr |
| Procter & Gamble Health Ltd | Healthcare | 3.46% | ₹38.10 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 3.46% | ₹38.07 Cr |
| Cipla Ltd | Healthcare | 3.43% | ₹37.78 Cr |
| Alkem Laboratories Ltd | Healthcare | 3.40% | ₹37.44 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 3.39% | ₹37.33 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 3.50% | ₹36.89 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 3.46% | ₹36.48 Cr |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 3.20% | ₹36.05 Cr |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 3.20% | ₹36.05 Cr |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 3.15% | ₹34.52 Cr |
| Gland Pharma Ltd | Healthcare | 3.01% | ₹34.45 Cr |
| Divi's Laboratories Ltd | Healthcare | 2.99% | ₹33.69 Cr |
| Divi's Laboratories Ltd | Healthcare | 2.99% | ₹33.69 Cr |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 2.98% | ₹33.59 Cr |
| Fortis Healthcare Ltd | Healthcare | 2.98% | ₹32.99 Cr |
| Divi's Laboratories Ltd | Healthcare | 2.88% | ₹32.98 Cr |
| Divi's Laboratories Ltd | Healthcare | 2.88% | ₹32.39 Cr |
| Eris Lifesciences Ltd | Healthcare | 2.81% | ₹32.23 Cr |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 2.81% | ₹32.18 Cr |
| Divi's Laboratories Ltd | Healthcare | 2.90% | ₹31.96 Cr |
| Procter & Gamble Health Ltd | Healthcare | 3.02% | ₹31.82 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 2.89% | ₹31.66 Cr |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 2.87% | ₹31.63 Cr |
| Max Healthcare Institute Ltd | Healthcare | 2.85% | ₹31.51 Cr |
| Caplin Point Laboratories Ltd | Healthcare | 2.70% | ₹31.00 Cr |
| Fortis Healthcare Ltd | Healthcare | 2.81% | ₹30.94 Cr |
| Aurobindo Pharma Ltd | Healthcare | 2.72% | ₹30.67 Cr |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 2.91% | ₹30.67 Cr |
| Divi's Laboratories Ltd | Healthcare | 2.87% | ₹30.26 Cr |
| Max Healthcare Institute Ltd | Healthcare | 2.74% | ₹30.16 Cr |
| Max Healthcare Institute Ltd | Healthcare | 2.61% | ₹29.90 Cr |
| Fortis Healthcare Ltd | Healthcare | 2.82% | ₹29.80 Cr |
| Aurobindo Pharma Ltd | Healthcare | 2.68% | ₹29.58 Cr |
| Aurobindo Pharma Ltd | Healthcare | 2.66% | ₹29.45 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 2.66% | ₹29.45 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 2.55% | ₹29.22 Cr |
| Aurobindo Pharma Ltd | Healthcare | 2.76% | ₹29.14 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 2.53% | ₹28.96 Cr |
| Fortis Healthcare Ltd | Healthcare | 2.55% | ₹28.65 Cr |
| Fortis Healthcare Ltd | Healthcare | 2.55% | ₹28.65 Cr |
| Eris Lifesciences Ltd | Healthcare | 2.54% | ₹28.52 Cr |
| Eris Lifesciences Ltd | Healthcare | 2.54% | ₹28.52 Cr |
| Aurobindo Pharma Ltd | Healthcare | 2.49% | ₹28.50 Cr |
| Aurobindo Pharma Ltd | Healthcare | 2.53% | ₹28.47 Cr |
| Aurobindo Pharma Ltd | Healthcare | 2.53% | ₹28.47 Cr |
| Divi's Laboratories Ltd | Healthcare | 2.59% | ₹28.45 Cr |
| Eris Lifesciences Ltd | Healthcare | 2.59% | ₹28.41 Cr |
| Eris Lifesciences Ltd | Healthcare | 2.49% | ₹28.08 Cr |
| Max Healthcare Institute Ltd | Healthcare | 2.48% | ₹27.91 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.41% | ₹27.67 Cr |
| Max Healthcare Institute Ltd | Healthcare | 2.62% | ₹27.61 Cr |
| Max Healthcare Institute Ltd | Healthcare | 2.45% | ₹27.55 Cr |
| Max Healthcare Institute Ltd | Healthcare | 2.45% | ₹27.55 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 2.41% | ₹27.13 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 2.41% | ₹27.13 Cr |
| Aurobindo Pharma Ltd | Healthcare | 2.47% | ₹27.10 Cr |
| Net Current Assets | Unspecified | 2.34% | ₹26.78 Cr |
| Max Healthcare Institute Ltd | Healthcare | 2.44% | ₹26.75 Cr |
| Caplin Point Laboratories Ltd | Healthcare | 2.42% | ₹26.65 Cr |
| Caplin Point Laboratories Ltd | Healthcare | 2.36% | ₹26.60 Cr |
| Caplin Point Laboratories Ltd | Healthcare | 2.36% | ₹26.60 Cr |
| Cipla Ltd | Healthcare | 2.51% | ₹26.48 Cr |
| Fortis Healthcare Ltd | Healthcare | 2.29% | ₹25.73 Cr |
| Caplin Point Laboratories Ltd | Healthcare | 2.35% | ₹25.72 Cr |
| Caplin Point Laboratories Ltd | Healthcare | 2.44% | ₹25.72 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 2.26% | ₹25.46 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 2.26% | ₹25.46 Cr |
| Caplin Point Laboratories Ltd | Healthcare | 2.22% | ₹25.00 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 2.25% | ₹24.72 Cr |
| Caplin Point Laboratories Ltd | Healthcare | 2.23% | ₹24.65 Cr |
| Procter & Gamble Health Ltd | Healthcare | 2.21% | ₹24.50 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 2.15% | ₹24.19 Cr |
| Sudeep Pharma Ltd. | 2.19% | ₹24.18 Cr | |
| Ipca Laboratories Ltd | Healthcare | 2.17% | ₹24.03 Cr |
| Sequent Scientific Ltd | Healthcare | 2.11% | ₹23.31 Cr |
| Ipca Laboratories Ltd | Healthcare | 2.19% | ₹23.11 Cr |
| Sudeep Pharma Ltd. | 2.19% | ₹23.05 Cr | |
| Sai Life Sciences Ltd. | Healthcare | 2.07% | ₹22.92 Cr |
| Ipca Laboratories Ltd | Healthcare | 2.03% | ₹22.84 Cr |
| Sequent Scientific Ltd | Healthcare | 2.07% | ₹22.81 Cr |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 2.06% | ₹22.79 Cr |
| Ipca Laboratories Ltd | Healthcare | 1.98% | ₹22.64 Cr |
| Eris Lifesciences Ltd | Healthcare | 2.05% | ₹22.58 Cr |
| Global Health Ltd | Healthcare | 2.05% | ₹22.54 Cr |
| Global Health Ltd | Healthcare | 2.02% | ₹22.33 Cr |
| Ipca Laboratories Ltd | Healthcare | 2.02% | ₹22.30 Cr |
| Sequent Scientific Ltd | Healthcare | 2.11% | ₹22.27 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 1.93% | ₹21.74 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 1.94% | ₹21.52 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 1.95% | ₹21.49 Cr |
| Global Health Ltd | Healthcare | 1.88% | ₹21.18 Cr |
| Anthem Biosciences Ltd. | Healthcare | 1.91% | ₹21.17 Cr |
| Sai Life Sciences Ltd. | Healthcare | 1.87% | ₹21.08 Cr |
| Sai Life Sciences Ltd. | Healthcare | 1.87% | ₹21.08 Cr |
| Ipca Laboratories Ltd | Healthcare | 1.92% | ₹21.04 Cr |
| Net Current Assets | Unspecified | 1.87% | ₹21.04 Cr |
| Net Current Assets | Unspecified | 1.87% | ₹21.04 Cr |
| Sai Life Sciences Ltd. | Healthcare | 1.89% | ₹20.86 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 1.84% | ₹20.68 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 1.84% | ₹20.68 Cr |
| Global Health Ltd | Healthcare | 1.96% | ₹20.65 Cr |
| Eris Lifesciences Ltd | Healthcare | 1.96% | ₹20.63 Cr |
| Sai Life Sciences Ltd. | Healthcare | 1.78% | ₹20.43 Cr |
| Eris Lifesciences Ltd | Healthcare | 1.84% | ₹20.37 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 1.85% | ₹20.36 Cr |
| Sai Life Sciences Ltd. | Healthcare | 1.80% | ₹20.31 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 1.80% | ₹20.30 Cr |
| Cipla Ltd | Healthcare | 1.83% | ₹20.22 Cr |
| Pfizer Ltd | Healthcare | 1.79% | ₹20.11 Cr |
| Pfizer Ltd | Healthcare | 1.79% | ₹20.11 Cr |
| Ipca Laboratories Ltd | Healthcare | 1.78% | ₹19.98 Cr |
| Ipca Laboratories Ltd | Healthcare | 1.78% | ₹19.98 Cr |
| Net Current Assets | Unspecified | 1.79% | ₹19.77 Cr |
| Sai Life Sciences Ltd. | Healthcare | 1.80% | ₹19.76 Cr |
| Metropolis Healthcare Ltd | Healthcare | 1.80% | ₹19.69 Cr |
| Anthem Biosciences Ltd. | Healthcare | 1.79% | ₹19.67 Cr |
| Pfizer Ltd | Healthcare | 1.77% | ₹19.54 Cr |
| Sequent Scientific Ltd | Healthcare | 1.73% | ₹19.47 Cr |
| Global Health Ltd | Healthcare | 1.77% | ₹19.44 Cr |
| Pfizer Ltd | Healthcare | 1.77% | ₹19.44 Cr |
| Metropolis Healthcare Ltd | Healthcare | 1.69% | ₹19.41 Cr |
| Global Health Ltd | Healthcare | 1.73% | ₹19.41 Cr |
| Global Health Ltd | Healthcare | 1.73% | ₹19.41 Cr |
| Global Health Ltd | Healthcare | 1.69% | ₹19.40 Cr |
| Pfizer Ltd | Healthcare | 1.75% | ₹19.25 Cr |
| Pfizer Ltd | Healthcare | 1.71% | ₹19.20 Cr |
| Sai Life Sciences Ltd. | Healthcare | 1.82% | ₹19.18 Cr |
| Anthem Biosciences Ltd. | Healthcare | 1.70% | ₹19.16 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 1.74% | ₹19.12 Cr |
| Metropolis Healthcare Ltd | Healthcare | 1.69% | ₹19.06 Cr |
| Metropolis Healthcare Ltd | Healthcare | 1.69% | ₹19.06 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 1.71% | ₹18.81 Cr |
| Sequent Scientific Ltd | Healthcare | 1.66% | ₹18.70 Cr |
| Sequent Scientific Ltd | Healthcare | 1.66% | ₹18.70 Cr |
| Metropolis Healthcare Ltd | Healthcare | 1.66% | ₹18.68 Cr |
| Metropolis Healthcare Ltd | Healthcare | 1.69% | ₹18.66 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 1.61% | ₹18.45 Cr |
| Metropolis Healthcare Ltd | Healthcare | 1.66% | ₹18.41 Cr |
| Marksans Pharma Ltd | Healthcare | 1.65% | ₹18.26 Cr |
| Metropolis Healthcare Ltd | Healthcare | 1.72% | ₹18.12 Cr |
| Anthem Biosciences Ltd. | Healthcare | 1.71% | ₹18.09 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 1.70% | ₹17.96 Cr |
| Anthem Biosciences Ltd. | Healthcare | 1.58% | ₹17.75 Cr |
| Anthem Biosciences Ltd. | Healthcare | 1.58% | ₹17.75 Cr |
| Pfizer Ltd | Healthcare | 1.67% | ₹17.62 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 1.53% | ₹17.56 Cr |
| Marksans Pharma Ltd | Healthcare | 1.50% | ₹17.17 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 1.55% | ₹17.15 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 1.60% | ₹16.84 Cr |
| Sequent Scientific Ltd | Healthcare | 1.48% | ₹16.23 Cr |
| Anthem Biosciences Ltd. | Healthcare | 1.46% | ₹16.02 Cr |
| Anthem Biosciences Ltd. | Healthcare | 1.39% | ₹15.98 Cr |
| Windlas Biotech Ltd | Healthcare | 1.39% | ₹15.87 Cr |
| Sudeep Pharma Ltd. | 1.41% | ₹15.86 Cr | |
| Marksans Pharma Ltd | Healthcare | 1.44% | ₹15.86 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 1.50% | ₹15.83 Cr |
| Marksans Pharma Ltd | Healthcare | 1.48% | ₹15.58 Cr |
| Pfizer Ltd | Healthcare | 1.33% | ₹15.27 Cr |
| Windlas Biotech Ltd | Healthcare | 1.35% | ₹15.18 Cr |
| Windlas Biotech Ltd | Healthcare | 1.35% | ₹15.18 Cr |
| Sudeep Pharma Ltd. | 1.37% | ₹15.07 Cr | |
| Sequent Scientific Ltd | Healthcare | 1.31% | ₹14.98 Cr |
| Biocon Ltd | Healthcare | 1.29% | ₹14.83 Cr |
| Windlas Biotech Ltd | Healthcare | 1.33% | ₹14.54 Cr |
| Marksans Pharma Ltd | Healthcare | 1.26% | ₹14.19 Cr |
| Net Current Assets | Unspecified | 1.24% | ₹14.00 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 1.26% | ₹14.00 Cr |
| Marksans Pharma Ltd | Healthcare | 1.22% | ₹13.75 Cr |
| Marksans Pharma Ltd | Healthcare | 1.22% | ₹13.75 Cr |
| Windlas Biotech Ltd | Healthcare | 1.26% | ₹13.30 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 1.13% | ₹12.90 Cr |
| Syngene International Ltd | Healthcare | 1.12% | ₹12.85 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 1.16% | ₹12.73 Cr |
| Net Current Assets | Unspecified | 1.20% | ₹12.71 Cr |
| Windlas Biotech Ltd | Healthcare | 1.13% | ₹12.50 Cr |
| Marksans Pharma Ltd | Healthcare | 1.14% | ₹12.46 Cr |
| Windlas Biotech Ltd | Healthcare | 1.13% | ₹12.46 Cr |
| Windlas Biotech Ltd | Healthcare | 1.09% | ₹12.28 Cr |
| Ami Organics Ltd | Healthcare | 1.15% | ₹12.10 Cr |
| Ami Organics Ltd | Healthcare | 1.08% | ₹12.09 Cr |
| Ami Organics Ltd | Healthcare | 1.08% | ₹12.09 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 1.09% | ₹12.05 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 1.09% | ₹12.00 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 1.05% | ₹11.99 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 1.06% | ₹11.98 Cr |
| Biocon Ltd | Healthcare | 1.06% | ₹11.95 Cr |
| Biocon Ltd | Healthcare | 1.09% | ₹11.94 Cr |
| Ami Organics Ltd | Healthcare | 1.07% | ₹11.87 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 1.05% | ₹11.86 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 1.05% | ₹11.86 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 1.08% | ₹11.86 Cr |
| Ami Organics Ltd | Healthcare | 1.03% | ₹11.84 Cr |
| Ami Organics Ltd | Healthcare | 1.07% | ₹11.76 Cr |
| Syngene International Ltd | Healthcare | 1.06% | ₹11.72 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 1.04% | ₹11.70 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 1.04% | ₹11.70 Cr |
| Syngene International Ltd | Healthcare | 1.04% | ₹11.70 Cr |
| Syngene International Ltd | Healthcare | 1.04% | ₹11.70 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 1.02% | ₹11.68 Cr |
| Syngene International Ltd | Healthcare | 1.04% | ₹11.67 Cr |
| Ami Organics Ltd | Healthcare | 1.03% | ₹11.62 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 1.09% | ₹11.50 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 1.03% | ₹11.30 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 1.07% | ₹11.28 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 1.00% | ₹11.26 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 0.98% | ₹11.23 Cr |
| Syngene International Ltd | Healthcare | 1.02% | ₹11.21 Cr |
| Biocon Ltd | Healthcare | 0.99% | ₹11.16 Cr |
| Biocon Ltd | Healthcare | 0.99% | ₹11.16 Cr |
| Net Current Assets | Unspecified | 1.02% | ₹11.14 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 1.04% | ₹10.98 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 0.99% | ₹10.92 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 0.98% | ₹10.85 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 0.99% | ₹10.81 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 0.96% | ₹10.80 Cr |
| Ami Organics Ltd | Healthcare | 0.98% | ₹10.78 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 0.96% | ₹10.77 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 0.96% | ₹10.77 Cr |
| Jubilant Pharmova Ltd | Healthcare | 0.93% | ₹10.71 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 0.93% | ₹10.69 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 0.95% | ₹10.68 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 0.95% | ₹10.68 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 0.97% | ₹10.66 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 0.94% | ₹10.63 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 0.94% | ₹10.61 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 0.94% | ₹10.45 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 0.94% | ₹10.38 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 0.97% | ₹10.26 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 0.93% | ₹10.23 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 0.88% | ₹9.92 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 0.88% | ₹9.89 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 0.88% | ₹9.89 Cr |
| Jubilant Pharmova Ltd | Healthcare | 0.88% | ₹9.87 Cr |
| Jubilant Pharmova Ltd | Healthcare | 0.88% | ₹9.87 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 0.90% | ₹9.86 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 0.87% | ₹9.81 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 0.87% | ₹9.81 Cr |
| Jubilant Pharmova Ltd | Healthcare | 0.87% | ₹9.77 Cr |
| Jubilant Pharmova Ltd | Healthcare | 0.88% | ₹9.68 Cr |
| Jubilant Pharmova Ltd | Healthcare | 0.87% | ₹9.62 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 0.88% | ₹9.60 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 0.85% | ₹9.36 Cr |
| Aarti Pharmalabs Ltd. | Healthcare | 0.84% | ₹9.27 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 0.85% | ₹8.95 Cr |
| Jubilant Pharmova Ltd | Healthcare | 0.83% | ₹8.81 Cr |
| Syngene International Ltd | Healthcare | 0.81% | ₹8.52 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 0.76% | ₹8.41 Cr |
| Orchid Pharma Ltd | Healthcare | 0.74% | ₹8.33 Cr |
| Biocon Ltd | Healthcare | 0.72% | ₹7.88 Cr |
| Biocon Ltd | Healthcare | 0.70% | ₹7.80 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 0.74% | ₹7.79 Cr |
| Jubilant Pharmova Ltd | Healthcare | 0.70% | ₹7.77 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 0.70% | ₹7.70 Cr |
| Syngene International Ltd | Healthcare | 0.69% | ₹7.60 Cr |
| Orchid Pharma Ltd | Healthcare | 0.69% | ₹7.59 Cr |
| Orchid Pharma Ltd | Healthcare | 0.65% | ₹7.40 Cr |
| Biocon Ltd | Healthcare | 0.70% | ₹7.34 Cr |
| Orchid Pharma Ltd | Healthcare | 0.65% | ₹7.26 Cr |
| Orchid Pharma Ltd | Healthcare | 0.65% | ₹7.26 Cr |
| Orchid Pharma Ltd | Healthcare | 0.64% | ₹7.02 Cr |
| Orchid Pharma Ltd | Healthcare | 0.66% | ₹6.99 Cr |
| Aarti Pharmalabs Ltd. | Healthcare | 0.62% | ₹6.50 Cr |
| Net Current Assets | Unspecified | 0.59% | ₹6.49 Cr |
| Laxmi Dental Ltd. | Healthcare | 0.56% | ₹6.44 Cr |
| Orchid Pharma Ltd | Healthcare | 0.56% | ₹6.20 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 0.54% | ₹6.10 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 0.52% | ₹5.78 Cr |
| Laxmi Dental Ltd. | Healthcare | 0.45% | ₹4.96 Cr |
| Laxmi Dental Ltd. | Healthcare | 0.43% | ₹4.80 Cr |
| Laxmi Dental Ltd. | Healthcare | 0.43% | ₹4.80 Cr |
| Laxmi Dental Ltd. | Healthcare | 0.37% | ₹4.20 Cr |
| Laxmi Dental Ltd. | Healthcare | 0.37% | ₹4.13 Cr |
| Laxmi Dental Ltd. | Healthcare | 0.26% | ₹2.92 Cr |
| Laxmi Dental Ltd. | Healthcare | 0.27% | ₹2.87 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 0.01% | ₹0.14 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 0.01% | ₹0.14 Cr |
| Others Cblo | Unspecified | 0.01% | ₹0.11 Cr |
| Others Cblo | Unspecified | 0.01% | ₹0.11 Cr |
| Others Cblo | Unspecified | 0.01% | ₹0.11 Cr |
| Others Cblo | Unspecified | 0.01% | ₹0.11 Cr |
| Others Cblo | Unspecified | 0.01% | ₹0.10 Cr |
| Others Cblo | Unspecified | 0.01% | ₹0.10 Cr |
| Others Cblo | Unspecified | 0.01% | ₹0.09 Cr |
| Others Cblo | Unspecified | 0.01% | ₹0.09 Cr |
Top Equity Funds
| Fund Names | NAV | 3Yr | 5Yr | 52 weeks high |
|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹40.71 | 28.14% | 18.49% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹37.58 | 27.07% | 17.46% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹34.05 | 25.80% | 16.15% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹30.74 | 24.14% | 14.52% | - |
Frequently Asked Questions
UTI Healthcare Fund Direct-growth
What is the current AUM of UTI Healthcare Fund Direct-growth?
As of Thu Jul 31, 2025, UTI Healthcare Fund Direct-growth manages assets worth ₹1,146.1 crore
What is the long-term performance of UTI Healthcare Fund Direct-growth?
- 3 Years CAGR: 26.53%
- 5 Years CAGR: 16.66%
- Since Inception: 15.33%
What is the portfolio composition of UTI Healthcare Fund Direct-growth?
Equity: 98.21%, Debt: 0.01%, Others: 1.79%.
Who manages UTI Healthcare Fund Direct-growth?
UTI Healthcare Fund Direct-growth is managed by Kamal Gada from UTI Mutual Fund.
What is the market-cap allocation of UTI Healthcare Fund Direct-growth?
Large Cap: 25.29%, Mid Cap: 26.42%, Small Cap: 48.29%.
Which are the top companies UTI Healthcare Fund Direct-growth has invested in?
- Sun Pharmaceutical Industries Ltd – 9.84% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 9.76% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 9.77% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 9.77% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 9.61% of the fund's portfolio
Which are the major sectors UTI Healthcare Fund Direct-growth focuses on?
- Healthcare – 780.86% of the fund's portfolio
- Unspecified – 11.99% of the fund's portfolio
- Other – 7.15% of the fund's portfolio
Policybazaar does not endorse rates/returns or recommend any particular insurer, fund house, AMC (Asset Management Company), insurance and mutual fund product.
Please consult your financial advisor for an informed decision.
Past performance may not be indicative of future results.
The information presented on this page is not owned or generated by Policybazaar. The data has been collected from publicly available sources and online research. We do not claim any ownership or guarantee the accuracy, completeness, or timeliness of this information. It is shared solely for the informational purpose of the viewer and should not be considered as financial advice.
Policybazaar is not acting as a financial advisor, broker, or agent for any mutual fund mentioned here.
Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing.
Policybazaar shall not be held responsible or liable for any losses, damages, or decisions made based on the information provided on this page.
For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product. For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product.
For more details on risk factors, terms, and conditions, please read the sales brochure and benefit illustration carefully before concluding a sale.
Policybazaar is a registered Insurance Broker | Registration No. 742, Registration Code No. IRDA/ DB 797/ 19, Valid till 09/06/2024, License category- Direct Broker (Life & General) |CIN: U74999HR2014PTC053454 | Registered Office - Plot No.119, Sector - 44, Gurgaon, Haryana – 122001 |Visitors are hereby informed that their information submitted on the website may be shared with insurers. Product information is authentic and solely based on the information received from the insurers.©️ Copyright 2008-2025 policybazaar.com. All Rights Reserved
^Returns as on 10th Jan’25. Tata AIA Life Top 200 ULIP Fund has delivered 18% returns over the last 10 years. Past performance is not necessarily indicative of future results. This disclaimer is specifically regarding a ULIP fund and is not related to mutual funds. Source: Morningstar.





